Research
Overall research output
Count | Share | |
---|---|---|
Overall | 554 | 61.54 |
Overall Count and Share for 'Dana-Farber Cancer Institute (DFCI)' based on the 12-month time frame mentioned above.
Research outputs by subject area
Subject | Count | Share |
---|---|---|
Biological sciences | 337 | 38.29 |
Chemistry | 53 | 5.93 |
Earth & environmental sciences | 1 | 0.04 |
Health sciences | 289 | 34.42 |
Physical sciences | 53 | 5.00 |
Note: Articles may be assigned to more than one subject area, as a result the sum of the subject research outputs may not equal the overall research outputs.
Note: Hover over the donut graph to view the Share for each subject.
Nature Strategy Reports
Identify research insights to guide research strategy and grow your impact with our Nature Strategy reports.
-
Actionable insights into research performance.
-
Detailed analysis of strengths and weaknesses.
-
Covers all major disciplines and regions of the world.
Explore the topics behind the 75,000 papers in the Nature Index 2024 Research Leaders
Latest supplement
Relationships
- Harvard University
- Harvard Medical School (HMS)
- Dana-Farber Cancer Institute (DFCI)
Affiliated joint institutions and consortia
- ASAN Center for Cancer Genome Discovery (ASAN-CCGD)
- Break Through Cancer
- CLL Research Consortium (CRC)
- Center for Cancer Systems Biology (CCSB)
- Center for Molecular Imaging Research (CMIR)
- Children's Oncology Group (COG)
- Clinical Sequencing Exploratory Research (CSER)
- Collaboration for AIDS Vaccine Discovery (CAVD)
- Dana-Farber/Boston Children's Cancer and Blood Disorders Center
- Dana-Farber/Brigham and Women’s Cancer Center (DF/BWCC)
- Elucidating Loci Involved in Prostate Cancer Susceptibility (ELLIPSE)
- Hansjorg Wyss Institute for Biologically Inspired Engineering
- Harvard Stem Cell Institute (HSCI)
- ICGC Breast Cancer Project: Triple Negative/Lobular/Other
- ImmGen Consortium
- Joint Center for Cancer Precision Medicine
- Massachusetts Consortium on Pathogen Readiness (MASSCPR)
- Multiple Myeloma Research Consortium (MMRC)
- Parker Institute for Cancer Immunotherapy